BioRegenx, Inc.
BRGX
$0.0115
-$0.0005-4.17%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.62M | -25.50M | -7.36M | -9.48M | -6.52M |
| Total Depreciation and Amortization | 2.03M | 2.52M | 1.95M | 1.37M | 504.10K |
| Total Amortization of Deferred Charges | 49.20K | 58.90K | 44.60K | 36.00K | 11.20K |
| Total Other Non-Cash Items | 19.69M | 21.89M | 4.50M | 7.00M | 4.79M |
| Change in Net Operating Assets | 518.30K | 564.10K | 171.10K | 125.90K | -67.50K |
| Cash from Operations | -323.50K | -465.50K | -699.70K | -952.00K | -1.28M |
| Capital Expenditure | 399.00K | 209.60K | 209.60K | 209.60K | -189.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 1.40K | 2.80K | 2.80K | 2.80K | 1.40K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.45M | 18.45M | 18.24M | 18.24M | -202.10K |
| Cash from Investing | 18.85M | 18.66M | 18.46M | 18.46M | -390.00K |
| Total Debt Issued | -147.20K | 152.80K | 153.90K | 168.30K | 373.00K |
| Total Debt Repaid | 32.80K | 25.80K | 17.90K | 9.90K | -56.10K |
| Issuance of Common Stock | -- | -- | 527.10K | 590.30K | 1.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.44M | -18.44M | -18.44M | -18.44M | -- |
| Cash from Financing | -18.56M | -18.26M | -17.74M | -17.67M | 1.32M |
| Foreign Exchange rate Adjustments | -200.00 | 2.90K | -2.00K | 600.00 | 15.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.60K | -67.00K | 12.10K | -168.00K | -335.30K |